PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Altys Group, Exclusive Distributor of ForaCare Suisse AG Products in South Africa, Launches the FORA Diamond MINI Blood Glucose Monitor in Partnership with Discovery Health

Altys Group has partnered with Discovery Health, which manages South Africa's largest open medical scheme and 13 closed schemes, to offer the Diamond MINI to all Discovery Health Medical Scheme members excluding members of Keycare plans.

Altys Group, Exclusive Distributor of ForaCare Suisse AG Products in South Africa, Launches the FORA Diamond MINI Blood Glucose Monitor in Partnership with Discovery Health
2014-04-24
JOHANNESBURG, SOUTH AFRICA, April 24, 2014 (Press-News.org) Altys Group announced the launch of the ForaCare Suisse AG FORA Diamond MINI blood glucose monitor in South Africa. An exclusive distributor of ForaCare since 2013, Altys Group has partnered with Discovery Health, which manages South Africa's largest open medical scheme and 13 closed schemes, to offer the Diamond MINI to all Discovery Health Medical Scheme members excluding members of Keycare plans. Eligible members can receive a free Diamond MINI from MedXpress and Dis-Chem stores as part of a diabetes care program.

The FORA Diamond MINI blood glucose monitor is a leading edge daily health management solution for patients with diabetes-related illnesses and has the distinction of being the world's first glucose monitor with dual mobile platform connectivity across iOS and Android devices. Bluetooth and USB capabilities keep patients confidently connected, and true to its name, the Diamond MINI is small enough for patients to carry with them and use discreetly as needed. Patients pair the Diamond MINI with the iFORA app to track their daily, weekly and monthly glucose trends in order to identify and modify the lifestyle choices that affect their glucose levels.

Discovery Health estimates that up to 60% of diabetes care costs are related to complications and, therefore, expects that the use of the Diamond MINI with the iFORA app and telehealth option will enhance cost effectiveness and efficiency of self-care and improve doctor-patient communication. The telehealth option in the iFORA app allows patients to upload daily glucose levels to Discovery HealthID for access and variation assessment by their doctors, who can then modify treatment based on real-time information. Altys and Discovery have agreed to add the test strips for the Diamond MINI to the chronic disease formulary list, so that it is available to diabetic members on all plans.

"Altys Group is proud to offer the FORA Diamond MINI in our market, in conjunction with Discovery Health, to help patients stay on top of their glucose monitoring needs when on the go," stated Alain MICHEL, Managing Director of Altys Group. "Everyone deserves to have peace of mind in the management of their health without compromising the activities that enhance their life."

"We could not be more pleased to have Altys Group as an exclusive distributor and partner in our mission to improve the lives of people affected by diabetes," said Ty-Minh Tan, CEO of ForaCare Suisse AG. "Patients and healthcare providers alike can be confident that the FORA Diamond MINI meets the highest ISO measurement standards and offers Advanced Superior Sip In (ASSI) test strip technology for the highest test precision."

To increase awareness of the new product and build an online community for people affected by diabetes-related health concerns, Altys Group has created a Facebook page where visitors can learn more and share their personal experiences: https://www.facebook.com/foraafrica.

About ForaCare Suisse AG:

ForaCare provides FDA cleared and CE marked innovative health monitoring devices that provide a simple connection to the FORA system. Our ultimate vision is to employ innovative technologies and services in expanding the scope of total health management platforms and to improve the quality of self-homecare for diabetes and hypertension patients. For more information, please visit: http://www.foracare.ch/

Contact:
Elena Birrer
+41-71-220-1001
Email: elena.birrer@foracare.com
Website: http://www.foracare.ch

About Altys Group:

Altys Group is a provider of breakthrough technology solutions for health, fitness and wellness including mobile health, telemonitoring and encryption for mobile communication devices. Headquartered in Johannesburg, South Africa, Altys Group focuses on customer service and performance through dedicated teamwork.

For more information, please visit www.altysgroup.com

Contact:
Ann Basson
+27-82-8607197
Email: fora@altysgroup.com

SOURCE Altys Group South Africa

[Attachments] See images for this press release:
Altys Group, Exclusive Distributor of ForaCare Suisse AG Products in South Africa, Launches the FORA Diamond MINI Blood Glucose Monitor in Partnership with Discovery Health Altys Group, Exclusive Distributor of ForaCare Suisse AG Products in South Africa, Launches the FORA Diamond MINI Blood Glucose Monitor in Partnership with Discovery Health 2

ELSE PRESS RELEASES FROM THIS DATE:

Great Minds in STEM and U.S. Department of Defense Present "Sneak Peek" Event

2014-04-24
Great Minds in STEM (GMiS), in conjunction with the U.S. Department of Defense (DoD), will proudly showcase a Viva Technology Program during the 3rd USA Science and Engineering Festival Sneak Peek Friday, on April 25, 2014. The Viva Technology, GMiS flagship K-12 STEM awareness program, will host 160 Washington D.C.students from Howard University Middle School and McKinley Technology Center. This special event themed, Celebrate Diversity in STEM!, will be held at the Walter E. Washington Convention Center, in Washington D.C. Students will experience STEM project-based ...

Eating Sugar Doubles Risk of Death in Cancer Patients, According to Nature Works Best's Groundbreaking Study

2014-04-24
A seven-year study of cancer patients, by Dr. Colleen Huber, NMD and her team at Nature Works Best, an alternative cancer clinic in Tempe, Arizona, exposes a severe threat to the survival of cancer patients - the consumption of sweetened food or drink. Dr. Huber led a team of physicians in a seven-year study where cancer patients avoided all types of sugar, including honey, maple syrup, corn syrup, high fructose corn syrup, plant nectars, alcohol and fruit juices. This is the first large, human, interventional study that has indicted sugar as deadly for cancer patients. ...

Rabbit TV Announces Launch of Streaming Live TV Channels Amidst Aereo Controversy

2014-04-24
As Aereo defends its live TV streaming service in front of the Supreme Court, Rabbit TV today announced a similar feature added to its popular eMedia guide, giving its 3 million+ users easy access to nearly 100 live TV stations over the web, including popular US stations like The CW, PBS, Ion, Univision, Telemundo, This, and MeTV, to name a few. The offering also incorporates international channels like Eurosport, RT, and ZDF, along with popular news, shopping and variety channels such as Bloomberg, MSNBC, QVC, HSN, and various others. The twist is that all of these channels ...

Play2Shop.com: Website Combines Free Casual Gaming With Innovative Cash Back Shopping and Unique Fundraising Opportunities

Play2Shop.com: Website Combines Free Casual Gaming With Innovative Cash Back Shopping and Unique Fundraising Opportunities
2014-04-24
Play2Shop.com is the first online community that has taken the "free" casual gaming experience to a whole new level - giving its members fun and novel ways to earn free rewards, buy goods, win auction items and even raise money for great charities! "Retailers are drawn to Play2Shop.com because of its unique shopping and free casual gaming platform that drives traffic, engages and entertains user's, builds brand loyalty, and most of all, helps drive sales back to our merchant partners!" said John Benton, Play2Shop.com's CEO. "Members love Play2Shop.com because of our ...

Use of frozen material for fecal transplant successfully treats C. difficile infection

2014-04-24
A pilot study by Massachusetts General Hospital (MGH) investigators may lead to greater availability and acceptability of an unusual treatment for a serious medical problem – use of fecal material from healthy donors to treat recurrent diarrhea caused by the Clostridium difficile (C. difficile) bacteria. In their paper being published online in the journal Clinical Infectious Diseases, the researchers report that use of prescreened frozen fecal material from donors unrelated to patients was as successful in curing recurrent C. difficile infection as was the use of fresh ...

Pilot study suggests ways to widen access to fecal transplants for C. diff infections

2014-04-24
Using frozen stool from healthy, unrelated donors was safe and effective in treating patients with serious, relapsing diarrhea caused by Clostridium difficile, according to a new pilot study published in Clinical Infectious Diseases and available online. Known as fecal microbiota transplantation, the treatment was equally effective whether given via a colonoscope or a nasogastric tube. The findings suggest approaches that may make this promising treatment more readily available to patients. A growing concern, C. difficile causes 250,000 infections requiring hospitalization ...

Pregnancy complications may be more common in immigrants from certain regions

2014-04-24
TORONTO, April 24, 2014 – Pregnant immigrants from Sub-Saharan Africa, Latin America and Caribbean islands may require increased monitoring during pregnancy, according to new research from St. Michael's Hospital. The study, published today in the British Journal of Obstetrics and Gynaecology, assessed the differences in preeclampsia and eclampsia rates among immigrants and native-born women in six high-immigration countries – Australia (Victoria), Canada (Ontario), Denmark, Sweden, Spain (Catalonia and Valencia) and the United States (California, New Jersey and New York ...

Moffitt Cancer Center's phase 3 study may be game-changer for acute myeloid leukemia

2014-04-24
Moffitt Cancer Center researchers say clinical trials for a new experimental drug to treat acute myeloid leukemia (AML) are very promising. Patients treated with CPX-351, a combination of the chemotherapeutic drugs cytarabine and daunorubicin, are showing better responses than patients treated with the standard drug formulation. "Acute myeloid leukemia is an aggressive blood cancer with very low rates of treatment success, especially in older patients," explained Jeffrey Lancet, M.D., senior member of the Department of Malignant Hematology and chief of the Leukemia ...

It's a bubble, but not as we know it

Its a bubble, but not as we know it
2014-04-24
Multi-sensory technology that creates soap bubbles, which can have images projected onto them or when the bubbles are burst release a scent, will be unveiled at an international conference later this month. The research paper, to be presented at one of the world's most important conferences on human-computer interfaces - ACM CHI 2014 [26 April-1 May], could be used in areas such as gaming or education and encourage a new way of thinking about multi-sensory technologies. SensaBubble, led by Professor Sriram Subramanian from the University of Bristol's Department of ...

The Lancet Global Health: Recurrent violence linked to substantially higher rates of mental disorders in post-conflict communities

2014-04-24
In the aftermath of war, communities who continue to experience repeated violence could have a major escalation in rates of post-traumatic stress disorder (PTSD) and severe distress, suggests new research published in The Lancet Global Health journal. In 2004, Dr Derrick Silove from the University of New South Wales in Sydney, Australia, and colleagues conducted a survey to estimate the prevalence of common mental disorders among 1022 adults (600 from a rural village and 422 from an urban district) in Timor Leste four years after the end of a long-running and violent ...

LAST 30 PRESS RELEASES:

$3 million NIH grant funds national study of Medicare Advantage’s benefit expansion into social supports

Amplified Sciences achieves CAP accreditation for cutting-edge diagnostic lab

Fred Hutch announces 12 recipients of the annual Harold M. Weintraub Graduate Student Award

Native forest litter helps rebuild soil life in post-mining landscapes

Mountain soils in arid regions may emit more greenhouse gas as climate shifts, new study finds

Pairing biochar with other soil amendments could unlock stronger gains in soil health

Why do we get a skip in our step when we’re happy? Thank dopamine

UC Irvine scientists uncover cellular mechanism behind muscle repair

Platform to map living brain noninvasively takes next big step

Stress-testing the Cascadia Subduction Zone reveals variability that could impact how earthquakes spread

We may be underestimating the true carbon cost of northern wildfires

Blood test predicts which bladder cancer patients may safely skip surgery

Kennesaw State's Vijay Anand honored as National Academy of Inventors Senior Member

Recovery from whaling reveals the role of age in Humpback reproduction 

Can the canny tick help prevent disease like MS and cancer?

Newcomer children show lower rates of emergency department use for non‑urgent conditions, study finds

Cognitive and neuropsychiatric function in former American football players

From trash to climate tech: rubber gloves find new life as carbon capturers materials

A step towards needed treatments for hantaviruses in new molecular map

Boys are more motivated, while girls are more compassionate?

Study identifies opposing roles for IL6 and IL6R in long-term mortality

AI accurately spots medical disorder from privacy-conscious hand images

Transient Pauli blocking for broadband ultrafast optical switching

Political polarization can spur CO2 emissions, stymie climate action

Researchers develop new strategy for improving inverted perovskite solar cells

Yes! The role of YAP and CTGF as potential therapeutic targets for preventing severe liver disease

Pancreatic cancer may begin hiding from the immune system earlier than we thought

Robotic wing inspired by nature delivers leap in underwater stability

A clinical reveals that aniridia causes a progressive loss of corneal sensitivity

Fossil amber reveals the secret lives of Cretaceous ants

[Press-News.org] Altys Group, Exclusive Distributor of ForaCare Suisse AG Products in South Africa, Launches the FORA Diamond MINI Blood Glucose Monitor in Partnership with Discovery Health
Altys Group has partnered with Discovery Health, which manages South Africa's largest open medical scheme and 13 closed schemes, to offer the Diamond MINI to all Discovery Health Medical Scheme members excluding members of Keycare plans.